COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.

Farren Basil Shaw Briggs Farrah J Mateen Hollie K SchmidtKeisha M CurrieHeather M SiefersSlavka CrouthamelBruce F BeboJulie FiolMichael K RackeKevin C O'ConnorLaura G KolaczkowskiPhyllis KleinSara LoudRobert Nicholas McBurney

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

SARS-CoV-2 vaccine reactogenicity profiles and the associated factors in this convenience sample of PwMS appear similar to those reported in the general population. PwMS on specific DMTs were less likely to report vaccine reactions. Overall, the short-term vaccine reactions experienced in the study population were mostly self-limiting, including pain at the injection site, fatigue, headache, and fever.

Keyphrases

sars cov
multiple sclerosis
coronavirus disease
chronic pain
respiratory syndrome coronavirus
pain management
neuropathic pain
spinal cord
white matter
physical activity
sleep quality
spinal cord injury